| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 126.61 | 0.00 (0.00%) | 77.81 - 131.33 | 6.1 thousand (Below Avg) |
Market data as of 4:01PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 126.61 |
| Day's Range | -- - -- |
| Market Cap | 13.4B |
| Avg Volume (10 Day) | 887.6K |
| Price/Earnings (Trailing 12 Mo.) | 30.4x |
| Earnings Per Share (Trailing 12 Mo.) | 4.16 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Pass |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
NxStage Announces New Agreements with DaVita
PR Newswire - Tuesday 05/21/2013 5:09 PM ET
DaVita’s Patient Pathways Wins Top Honors for Excellence in Discharge Planning
Business Wire - Wednesday 05/15/2013 8:00 AM ET
DaVita Gives More Than $1.75 Million to Communities Across the US
Business Wire - Monday 05/13/2013 8:00 AM ET
BioScrip Reports First Quarter 2013 Financial Results
PR Newswire - Wednesday 05/08/2013 5:26 PM ET
DaVita HealthCare Partners Inc. 1st Quarter 2013 Results
Business Wire - Tuesday 05/07/2013 4:03 PM ET
U.S. District Court Dismisses Case Against DaVita
Business Wire - Thursday 05/02/2013 5:28 PM ET
DaVita HealthCare Partners Surpasses 2,000 Clinics, 50,000 Teammates as of Q1 2013
Business Wire - Thursday 05/02/2013 7:00 AM ET
DaVita Awarded Ambulatory Health Care Accreditation for Inpatient Kidney Care Services by The Joint Commission
Business Wire - Monday 04/29/2013 6:00 AM ET
| DVA | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 26.22% | |
| Net Income Growth (1yr) | -11.08% | |
| Total Debt/Equity | 2.24 | |
| LT Debt/Equity | 2.18 | |
| Earnings Yield | 3.29% | |
| Price/Sales | 1.46 |
| Company | Last | Change |
|---|---|---|
| Fresenius Medical Care AG & Co KGaA | 34.35 | 0.00% |
| Catamaran Corp | 50.38 | 0.00% |
| MEDNAX Inc | 93.40 | 0.00% |
| HealthSouth Corp | 30.40 | 0.00% |
| Acadia Healthcare Company Inc | -- | -- |
Data is delayed by at least 15 min.